Canine arthritis may be a chronic condition that ends up in inflammation of 1 or a lot of joints and progresses over time if left untreated. the foremost usually affected joints embody the knee, elbow, shoulder, hip and back. There are numerous causes of inflammatory disease in dogs like traumatic injuries, obesity, failure of correct bone development and lots of others. There are many sorts of canine arthritis however the foremost common is arthritis. It affects one in five adult dogs. The prevalence of arthritis will increase with the age of canines. It’s a chronic disease characterised by the loss of gristle. It conjointly includes alternative abnormalities like osteophytotic in response to inflammation and pain.
How Big is the Canine Arthritis Treatment Market?
The Canine Arthritis Treatment Market is expected to exceed more than US$ 3.50 Billion by 2028 at a CAGR of 4.5% in the given forecast period.
The Canine Arthritis Treatment Market has been segmented as below:
By Treatment Type:
By Route of Administration:
By End-User:
By Regional Analysis:
The Canine Arthritis Treatment Market is segmented on the lines of its treatment type, route of administration, end users and regional. Basis of End-User is segmented into Veterinary Hospitals and Clinics, Retail Pharmacies, Drug Stores and E-commerce. Based on Treatment Type it covers Non-steroidal anti-inflammatory drugs, Opioids and Stem Cell Therapy. Based on route of administration it covers Oral and Injectable. The Canine Arthritis Treatment Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Canine Arthritis Treatment Market and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Canine Arthritis Treatment Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
Report Scope:
The scope of the report includes a detailed study of Canine Arthritis Treatment Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Elanco (Eli Lilly and Company), Boehringer Ingelheim, Zoetis Inc., Vetoquinol S.A., Bayer AG, Aratana Therapeutics Inc., Norbrook Laboratories Limited, VetStem Biopharma, and Dechra Pharmaceuticals Plc, among others. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Canine Arthritis Treatment Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Canine Arthritis Treatment Market.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our new reports:
Carpal Tunnel Release Systems Market
Disposable Laparoscopic Instruments Market
1. Introduction
1.1 Report Description
1.2 Markets Covered
1.3 Stakeholders
2. Research Methodology
2.1 Research Data
2.2 Market Size Estimation and Data Triangulation
2.3 Research Assumptions
3. Report Summary
4. Market Overview
4.1 Introduction
4.2 Drivers
4.3 Restrains
4.4 Industry Trends
4.5 Porter’s Five Forces Analysis
5. Canine Arthritis Treatment Market Analysis, By Treatment Type
5.1 Non-steroidal anti-inflammatory drugs
5.2 Opioids
5.3 Stem Cell Therapy
6. Canine Arthritis Treatment Market Analysis, By Route Of Administration
6.1 Oral
6.2 Injectable
7. Canine Arthritis Treatment Market Analysis, By End-User
7.1 Veterinary Hospitals and Clinics
7.2 Retail Pharmacies
7.3 Drug Stores
7.4 E-commerce
8. Canine Arthritis Treatment Market Analysis, By Region
8.1 North America
8.2 Europe
8.3 Asia-Pacific
8.4 Rest of the World
9. Competitive Overview
9.1 Introduction
9.2 New Product Launches
9.3 Acquisitions
9.4 Agreements, Partnerships, And Collaborations
9.5 Expansions
10. Company Profiles
10.1 Elanco (Eli Lilly and Company)
10.2 Norbrook Laboratories Limited
10.3 Aratana Therapeutics Inc.
10.4 Dechra Pharmaceuticals Plc
10.5 VetStem Biopharma
10.6 Zoetis Inc.
10.7 Vetoquinol S.A.
10.8 Boehringer Ingelheim
10.9 Bayer AG
The Canine Arthritis Treatment Market has been segmented as below:
By Treatment Type:
By Route of Administration:
By End-User:
By Regional Analysis:
SUBSCRIBE TO OUR NEWSLETTERS
